Literature DB >> 7871273

[Disulfiram (Esperal) toxicity. Apropos of 3 original cases].

O Dupuy1, F Flocard, C Vial, G Rode, N Charles, D Boisson, A Flechaire.   

Abstract

Prescribed since 1948 to control chronic alcoholism, disulfiram may cause severe toxicity as report in three cases of acute motive axonal polyneuritis. Disulfiram toxicity may present different clinical aspects: 1) Cytolytic hepatitis with fatal evolution in 30% of cases (fulminant hepatitis), and full recovery for the other 70%. The onset of the symptoms usually occurs as early as 15 days to a maximum of 6 months (most within 2 months) after initiation of treatment. 2) Severe optic neuritis with full recovery in 2 months. 3) Peripheral neuropathy usually dose dependent, with different clinical presentations: polyneuritis with sensory, motor, or both deficits, and few cases of tetraplegia. 4) Encephalopathy frequently associated with one of the precedent symptoms, having a favorable outcome (probably resulting in inhibition of dopamine-beta-hydroxylase by disulfiram). The mechanism of toxicity (direct or idiosyncractic) remain unclear. Disulfiram has been used safely in millions of people since 1948, and we have only few cases reports of severe toxicity. From a practical point of view, treated patients should benefit by a neurological examination once a month, ophtalmological examination every 2 months, and hepatic enzymes monitored twice a month during the 2 first months. This is the price to prevent and to detect side effects of disulfiram therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7871273     DOI: 10.1016/0248-8663(96)80667-9

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  9 in total

1.  Posterior reversible encephalopathy syndrome following disulfiram intoxication.

Authors:  Sandra Coppens; Gilles Naeije; Nicolas Mavroudakis
Journal:  J Neurol       Date:  2011-02-22       Impact factor: 4.849

Review 2.  Safety issues concerning the use of disulfiram in treating alcohol dependence.

Authors:  J Chick
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

3.  "Atypical" atypical Wernicke encephalopathy with axonopathy due to disulfiram intoxication.

Authors:  Manon Rival; Dimitri Renard; Eric Thouvenot; Ioana Ion
Journal:  Acta Neurol Belg       Date:  2022-01-10       Impact factor: 2.396

4.  CURRENT STATUS OF DISULFIRAM THERAPY.

Authors:  P K Chakraborty; H Singh; K J Divinakumar
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  Disulfiram-induced transient optic and peripheral neuropathy: a case report.

Authors:  A Orakzai; M Guerin; S Beatty
Journal:  Ir J Med Sci       Date:  2007-09-05       Impact factor: 1.568

Review 6.  mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse.

Authors:  Meriem Gaval-Cruz; David Weinshenker
Journal:  Mol Interv       Date:  2009-08

7.  Eliciting the low-activity aldehyde dehydrogenase Asian phenotype by an antisense mechanism results in an aversion to ethanol.

Authors:  E Garver; Q N Cao; M Aini; F Zhou; Y Israel
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

8.  A herbal composition of semen hoveniae, radix puerariae, and fructus schisandrae shows potent protective effects on acute alcoholic intoxication in rodent models.

Authors:  Jie Xiong; Yu Guo; Lu-Yi Li; Hang Hu; Xin-Lan Qu; Xi-Zhen Sun; Sheng-Hua Liu; Hui Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-15       Impact factor: 2.629

9.  Cell cycle specific radiosensitisation by the disulfiram and copper complex.

Authors:  Mathias Tesson; Giorgio Anselmi; Caitlin Bell; Robert Mairs
Journal:  Oncotarget       Date:  2017-07-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.